• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Impact of Antimicrobial Resistance Rates on Eradication of Helicobacter pylori in a US Population.

作者信息

Argueta Erick A, Alsamman Mohd Amer, Moss Steven F, D'Agata Erika M C

机构信息

Division of Gastroenterology, Rhode Island Hospital, Warren Alpert Medical School of Brown University, Providence, Rhode Island.

Division of Gastroenterology, Georgetown University Hospital, Washington, DC.

出版信息

Gastroenterology. 2021 May;160(6):2181-2183.e1. doi: 10.1053/j.gastro.2021.02.014. Epub 2021 Feb 9.

DOI:10.1053/j.gastro.2021.02.014
PMID:33577874
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9115583/
Abstract
摘要

相似文献

1
Impact of Antimicrobial Resistance Rates on Eradication of Helicobacter pylori in a US Population.抗菌药物耐药率对美国人群中幽门螺杆菌根除的影响
Gastroenterology. 2021 May;160(6):2181-2183.e1. doi: 10.1053/j.gastro.2021.02.014. Epub 2021 Feb 9.
2
Novel and Effective Therapeutic Regimens for in an Era of Increasing Antibiotic Resistance.抗生素耐药性不断增加的时代下针对[具体病症，原文缺失]的新型有效治疗方案
Front Cell Infect Microbiol. 2017 May 5;7:168. doi: 10.3389/fcimb.2017.00168. eCollection 2017.
3
Amoxicillin or tetracycline in bismuth-containing quadruple therapy as first-line treatment for infection.铋剂四联疗法中阿莫西林或四环素作为一线治疗 感染。
Gut Microbes. 2020 Sep 2;11(5):1314-1323. doi: 10.1080/19490976.2020.1754118. Epub 2020 May 2.
4
A Randomized Controlled Trial Shows that both 14-Day Hybrid and Bismuth Quadruple Therapies Cure Most Patients with Helicobacter pylori Infection in Populations with Moderate Antibiotic Resistance.一项随机对照试验表明，在抗生素耐药率中等的人群中，14 天的混合疗法和铋四联疗法都能治愈大多数幽门螺杆菌感染患者。
Antimicrob Agents Chemother. 2017 Oct 24;61(11). doi: 10.1128/AAC.00140-17. Print 2017 Nov.
5
Clarithromycin-Based Triple Therapy is Still Useful as an Initial Treatment for Infection in the Dominican Republic.基于克拉霉素的三联疗法仍可用作多米尼加共和国感染的初始治疗方法。
Am J Trop Med Hyg. 2017 May;96(5):1050-1059. doi: 10.4269/ajtmh.16-0729. Epub 2017 Feb 13.
6
Bismuth, lansoprazole, amoxicillin and metronidazole or clarithromycin as first-line Helicobacter pylori therapy.铋剂、兰索拉唑、阿莫西林和甲硝唑或克拉霉素作为一线幽门螺杆菌治疗。
Gut. 2015 Nov;64(11):1715-20. doi: 10.1136/gutjnl-2015-309900. Epub 2015 Sep 2.
7
In vitro antimicrobial susceptibility of Helicobacter pylori to nine antibiotics currently used in Central Italy.意大利中部目前使用的九种抗生素对幽门螺杆菌的体外抗菌敏感性
Scand J Gastroenterol. 2016 Mar;51(3):263-9. doi: 10.3109/00365521.2015.1092577. Epub 2015 Oct 7.
8
New single capsule of bismuth, metronidazole and tetracycline given with omeprazole versus quadruple therapy consisting of bismuth, omeprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: a Chinese prospective, randomized, multicentre trial.铋、甲硝唑和四环素单胶囊联合奥美拉唑与铋、奥美拉唑、阿莫西林和克拉霉素四联疗法治疗十二指肠溃疡患者幽门螺杆菌根除：一项中国前瞻性、随机、多中心试验。
J Antimicrob Chemother. 2018 Jun 1;73(6):1681-1687. doi: 10.1093/jac/dky056.
9
Effectiveness of two quadruple, tetracycline- or clarithromycin-containing, second-line, Helicobacter pylori eradication therapies.两种含四环素或克拉霉素的四联二线幽门螺杆菌根除疗法的有效性。
Aliment Pharmacol Ther. 2002 Mar;16(3):569-75. doi: 10.1046/j.1365-2036.2002.01220.x.
10
[Comparison of rifabutin- and levofloxacin-based third-line rescue therapies for Helicobacter pylori].基于利福布汀和左氧氟沙星的幽门螺杆菌三线挽救治疗的比较
Korean J Gastroenterol. 2012 Jun 25;59(6):401-6. doi: 10.4166/kjg.2012.59.6.401.

引用本文的文献

1
First regional consensus on the management of infection in the Middle East.中东地区关于感染管理的首个区域共识。
World J Gastroenterol. 2025 Jul 21;31(27):107138. doi: 10.3748/wjg.v31.i27.107138.
2
Antibiotic Resistance and Eradication Therapy.抗生素耐药性与根除疗法
Korean J Helicobacter Up Gastrointest Res. 2023 Sep;23(3):218-221. doi: 10.7704/kjhugr.2023.0044. Epub 2023 Sep 8.
3
Resistome and virulome determination in using next-generation sequencing with target-enrichment technology.使用靶向富集技术的下一代测序技术进行耐药基因组和毒力基因组的测定。
Microbiol Spectr. 2025 Apr;13(4):e0329824. doi: 10.1128/spectrum.03298-24. Epub 2025 Mar 5.
4
Potassium-Competitive Acid Blockers and Proton Pump Inhibitors: The Dynamic Duo of Acid Blockers.钾竞争性酸阻滞剂与质子泵抑制剂：酸阻滞剂的强力组合。
Gastroenterol Hepatol (N Y). 2024 Dec;20(12):733-738.
5
Antimicrobial Resistance and the Role of Next-Generation Sequencing.抗菌药物耐药性与新一代测序技术的作用
Gastroenterol Hepatol (N Y). 2024 Aug;20(8):469-476.
6
Potassium-Competitive Acid Blocker and Proton Pump Inhibitor-Based Regimens for First-Line Eradication: A Network Meta-Analysis.基于钾离子竞争性酸阻滞剂和质子泵抑制剂的一线根除方案：一项网状Meta分析
Gastro Hep Adv. 2022 Jun 17;1(5):824-834. doi: 10.1016/j.gastha.2022.06.009. eCollection 2022.
7
Comparative Efficacy and Safety of Potassium-Competitive Acid Blockers vs. Proton Pump Inhibitors for Peptic Ulcer with or without Infection: A Systematic Review and Network Meta-Analysis.钾离子竞争性酸阻滞剂与质子泵抑制剂治疗伴或不伴感染的消化性溃疡的疗效和安全性比较：一项系统评价和网状Meta分析
Pharmaceuticals (Basel). 2024 May 28;17(6):698. doi: 10.3390/ph17060698.
8
Culture-based susceptibility-guided tailored versus empirical concomitant therapy as first-line Helicobacter pylori treatment: A randomized clinical trial.基于培养的药敏指导下的个体化治疗与经验性联合治疗作为一线幽门螺杆菌治疗：一项随机临床试验。
United European Gastroenterol J. 2024 Sep;12(7):941-950. doi: 10.1002/ueg2.12609. Epub 2024 Jun 17.
9
Secondary Antibiotic Resistance after One or More Eradication Failure: A Genotypic Stool Analysis Study.一次或多次根除失败后的继发性抗生素耐药性：一项基因型粪便分析研究。
Antibiotics (Basel). 2024 Apr 7;13(4):336. doi: 10.3390/antibiotics13040336.
10
Effectiveness of Rifabutin-Based Regimens in Treating Helicobacter pylori Infections.基于利福布汀的治疗方案对幽门螺杆菌感染的疗效
Cureus. 2023 Dec 14;15(12):e50541. doi: 10.7759/cureus.50541. eCollection 2023 Dec.

本文引用的文献

1
Rifabutin-Based Triple Therapy (RHB-105) for Eradication: A Double-Blind, Randomized, Controlled Trial.利福布丁三联疗法（RHB-105）根除幽门螺杆菌：一项双盲、随机、对照试验。
Ann Intern Med. 2020 Jun 16;172(12):795-802. doi: 10.7326/M19-3734. Epub 2020 May 5.
2
Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions.幽门螺杆菌抗生素耐药性的流行情况：世界卫生组织区域的系统评价和荟萃分析。
Gastroenterology. 2018 Nov;155(5):1372-1382.e17. doi: 10.1053/j.gastro.2018.07.007. Epub 2018 Jul 7.
3
ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.美国胃肠病学会临床指南：幽门螺杆菌感染的治疗
Am J Gastroenterol. 2017 Feb;112(2):212-239. doi: 10.1038/ajg.2016.563. Epub 2017 Jan 10.
4
Helicobacter pylori Clarithromycin Resistance and Treatment Failure Are Common in the USA.在美国，幽门螺杆菌对克拉霉素耐药及治疗失败的情况很常见。
Dig Dis Sci. 2016 Aug;61(8):2373-2380. doi: 10.1007/s10620-016-4091-8. Epub 2016 Feb 29.
5
Antibiotic Resistance of Helicobacter pylori Among Male United States Veterans.美国男性退伍军人中幽门螺杆菌的抗生素耐药性
Clin Gastroenterol Hepatol. 2015 Sep;13(9):1616-24. doi: 10.1016/j.cgh.2015.02.005. Epub 2015 Feb 11.